Authors: JOHNSON FE HARRISON BR MCKIRGAN LW RAJU PI ROY TK VIRGO KS

Citation: Fe. Johnson et al., A PHASE-II EVALUATION OF PENTOXIFYLLINE COMBINED WITH RADIATION IN THE TREATMENT OF BRAIN METASTASES, International journal of oncology, 13(4), 1998, pp. 801-805

Authors: JOHNSON FE TOLMAN KC FARR SA MAWAD MR RAJU PI HUENEBURG LR SUTERA SP

Citation: Fe. Johnson et al., EFFECT OF CHRONIC ORAL PENTOXIFYLLINE ADMINISTRATION ON MURINE ERYTHROCYTE DEFORMABILITY, The Journal of surgical research, 63(2), 1996, pp. 387-392

Authors: RAJU PI ROY T MCDONALD RD HARRISON BR CRIM C HYERS TM MARSHALL SJ OHAR JA NAUNHEIM KS

Citation: Pi. Raju et al., IR-192, LOW-DOSE RATE ENDOBRONCHIAL BRACHYTHERAPY IN THE TREATMENT OFMALIGNANT AIRWAY-OBSTRUCTION, International journal of radiation oncology, biology, physics, 27(3), 1993, pp. 677-680

Authors: RAJU PI TOLMAN KC DAVIS PJ LUDDEN TM ROY TK JOHNSON FE

Citation: Pi. Raju et al., DISTRIBUTION AND METABOLISM OF PENTOXIFYLLINE IN NON-TUMOR-BEARING MICE, Journal of medicine, 24(6), 1993, pp. 353-368

Authors: JOHNSON FE TOLMAN KC FARR SA DAVIS PJ LUDDEN TM ROY TK RAJU PI

Citation: Fe. Johnson et al., SERUM LEVELS OF PENTOXIFYLLINE AND ITS METABOLITES IN NON-TUMOR-BEARING MICE AFTER CHRONIC ORAL PENTOXIFYLLINE ADMINISTRATION, Journal of medicine, 24(2-3), 1993, pp. 131-143